Edwards Lifesciences (EW) Tops Q3 EPS by 5c, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $94.44 +2.90%
EPS Growth %: +10.4%
Financial Fact:
Basic (in dollars per share): 0.66
Today's EPS Names:
PFBX, GOVB, VABK, More
EPS Growth %: +10.4%
Financial Fact:
Basic (in dollars per share): 0.66
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.07, $0.05 better than the analyst estimate of $1.02. Revenue for the quarter came in at $907 million versus the consensus estimate of $928.18 million.
GUIDANCE:
Edwards Lifesciences sees Q4 2018 EPS of $1.05-$1.20, versus the consensus of $1.21. Edwards Lifesciences sees Q4 2018 revenue of $950-1000 million, versus the consensus of $995.4 million.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- FTI Consulting (FCN) Tops Q3 EPS by 110c; offers guidance
- BridgeBio Pharma Inc. (BBIO) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
